Company Overview

Star Equity Holdings, Inc. (STRR) is a publicly traded diversified holding company that owns and operates businesses across the healthcare staffing and real estate / construction services industries. The company’s strategy centers on acquiring and managing operating subsidiaries that generate recurring revenue and cash flow while maintaining a flexible capital allocation model typical of holding companies.

The company’s primary revenue drivers are staffing services for healthcare providers and construction‑related services tied to residential and commercial real estate development. Star Equity primarily serves healthcare systems, hospitals, long‑term care facilities, and real estate developers in the United States. Its positioning as a small‑cap holding company allows it to pursue niche acquisitions, operational improvements, and opportunistic investments. Formerly known as Novation Companies, Inc., the company rebranded to Star Equity Holdings, Inc. in 2020 to reflect its broader investment mandate and multi‑sector focus.

Business Operations

Star Equity operates through two main business segments: Healthcare Staffing and Real Estate / Construction Services. The Healthcare Staffing segment provides temporary and permanent clinical staffing solutions, including nurses and allied health professionals, primarily through its subsidiary Greenstaff Medical and related staffing entities. Revenue in this segment is generated through contractual staffing placements with healthcare facilities, driven by workforce shortages and variable patient demand.

The Real Estate / Construction Services segment focuses on construction management, modular construction, and real estate development support, primarily through subsidiaries such as KBS Builders, Inc. Operations are predominantly domestic, with activities concentrated in select regional U.S. markets. The company does not report material international operations, though some staffing services may support clients with multi‑state or cross‑border operational footprints. Data inconclusive based on available public sources regarding material joint ventures outside the United States.

Strategic Position & Investments

Star Equity’s strategic direction emphasizes disciplined capital deployment into operating businesses with near‑term cash flow potential and long‑term value creation. Growth initiatives have included expanding the scale and service offerings of Greenstaff Medical, particularly in high‑demand clinical specialties and underserved geographic markets. The company has pursued bolt‑on acquisitions and organic growth rather than large transformational mergers.

Notable investments include the acquisition of Greenstaff Medical, which significantly increased the company’s exposure to healthcare services and recurring revenue. Star Equity continues to evaluate opportunities in healthcare services, construction, and other asset‑light or service‑oriented sectors. Emerging technology investments are limited; the company’s strategy remains focused on operational execution rather than venture‑stage innovation. Data inconclusive based on available public sources regarding material investments in emerging technologies.

Geographic Footprint

Star Equity Holdings is headquartered in the United States, with its principal executive offices located in New York. Its operating subsidiaries primarily serve customers across multiple U.S. states, with healthcare staffing operations supporting facilities in both urban and regional markets.

The company does not report significant physical operations outside North America, and its revenue is largely derived from domestic sources. While some client relationships may involve multinational healthcare operators or developers, Star Equity itself maintains a predominantly U.S.‑centric operational and investment footprint.

Leadership & Governance

Star Equity is led by an executive team with experience in capital markets, operations, and acquisitions, reflecting its holding company structure. Leadership emphasizes shareholder value creation through disciplined investment, cost control, and selective growth. The board and management team play an active role in capital allocation and subsidiary oversight.

Key executives include:

• Daniel C. Brauser – Chief Executive Officer and Chairman
• Kevin T. Breslin – Chief Financial Officer
• [Additional executive leadership] – Data inconclusive based on available public sources regarding verified current titles and roles beyond the CEO and CFO

The company’s governance framework aligns with U.S. public company standards, with oversight provided by an independent board of directors and disclosures made through regular filings with the U.S. Securities and Exchange Commission.